Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is 5.89%.The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 19.23%. Meridian Bioscience's revenue for the same period is $173.54 million.The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.50%. IDEXX Laboratories' PEG ratio is 1.91.The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.35%. Neogen's ROE for the same period is 10.90%.